| Literature DB >> 31690822 |
Arina Riabinska1, Daria Lehrmann2, Ron Daniel Jachimowicz2, Gero Knittel2, Christian Fritz2, Anna Schmitt2, Aenne Geyer2, Carola Heneweer3, Maike Wittersheim4, Lukas P Frenzel2,5, Alessandro Torgovnick2,5, Janica Lea Wiederstein5, Claudia Maria Wunderlich6, Monika Ortmann4, Arlette Paillard7, Wilhelm Wößmann8, Arndt Borkhardt9, Stefan Burdach10, Martin-Leo Hansmann11, Andreas Rosenwald12, Sven Perner13, Gita Mall14, Wolfram Klapper15, Andrea Merseburg16, Marcus Krüger5, Holger Grüll3, Thorsten Persigehl3, Frank Thomas Wunderlich6, Martin Peifer17,18, Olaf Utermöhlen7,17,19, Reinhard Büttner4,17, Filippo Beleggia2, Hans Christian Reinhardt20,21,22.
Abstract
The proximal DNA damage response kinase ATM is frequently inactivated in human malignancies. Germline mutations in the ATM gene cause Ataxia-telangiectasia (A-T), characterized by cerebellar ataxia and cancer predisposition. Whether ATM deficiency impacts on tumor initiation or also on the maintenance of the malignant state is unclear. Here, we show that Atm reactivation in initially Atm-deficient B- and T cell lymphomas induces tumor regression. We further find a reduced T cell abundance in B cell lymphomas from Atm-defective mice and A-T patients. Using T cell-specific Atm-knockout models, as well as allogeneic transplantation experiments, we pinpoint impaired immune surveillance as a contributor to cancer predisposition and development. Moreover, we demonstrate that Atm-deficient T cells display impaired proliferation capacity upon stimulation, due to replication stress. Altogether, our data indicate that T cell-specific restoration of ATM activity or allogeneic hematopoietic stem cell transplantation may prevent lymphomagenesis in A-T patients.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31690822 DOI: 10.1038/s41375-019-0618-2
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528